Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Abnormal Proliferation02:23

Abnormal Proliferation

4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Metastasis02:30

Metastasis

5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
Multiple Comparison Tests01:13

Multiple Comparison Tests

3.5K
Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
3.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Integrated analysis of mRNA and microRNA expression profiles reveals differential transcriptome signature in ischaemic and dilated cardiomyopathy induced heart failure.

Epigenetics·2020
Same author

Third Ventricle Cavernous Malformation and Obstructive Hydrocephalus Thought to Be a Colloid Cyst.

World neurosurgery·2020
Same author

Endovascular strategies for post-dissection aortic aneurysm (PDAA).

Journal of cardiothoracic surgery·2020
Same author

Stem cell-derived extracellular vesicles mitigate ageing-associated arterial stiffness and hypertension.

Journal of extracellular vesicles·2020
Same author

The ABO histo-blood group, endothelial activation, and acute respiratory distress syndrome risk in critical illness.

The Journal of clinical investigation·2020
Same author

Epstein-Barr virus infection in ulcerative colitis: a clinicopathologic study from a Chinese area.

Therapeutic advances in gastroenterology·2020

相关实验视频

Updated: May 6, 2026

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
13:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

12.4K

cMyc可以挑战 cTn吗?

Qing Li1,2, Chu-Jun Yang1,2, Rui Feng1

  • 1Department of Laboratory Medicine Center, Wuhan Asia Heart Hospital Affiliated to Wuhan University of Science and Technology, Wuhan 430022, China.

Laboratory medicine
|October 8, 2025
PubMed
概括

心脏肌结合蛋白C (cMyc) 提供了比高灵敏性心脏热素 (hs-cTn) 更早,更具体的急性冠状动脉综合征诊断. 这种生物标志物有可能显著改善早期检测和患者的治疗结果.

关键词:
急性冠状动脉综合征急性冠状动脉综合征心脏中的托罗邦尼 (troponin)在cMyc的临床应用中.心肌肌氨酸结合蛋白-C (cMyc) 的结合蛋白.

更多相关视频

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

15.9K
ACT1-CUP1 Assays Determine the Substrate-Specific Sensitivities of Spliceosomal Mutants in Budding Yeast
07:31

ACT1-CUP1 Assays Determine the Substrate-Specific Sensitivities of Spliceosomal Mutants in Budding Yeast

Published on: June 30, 2022

2.9K

相关实验视频

Last Updated: May 6, 2026

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
13:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

12.4K
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

15.9K
ACT1-CUP1 Assays Determine the Substrate-Specific Sensitivities of Spliceosomal Mutants in Budding Yeast
07:31

ACT1-CUP1 Assays Determine the Substrate-Specific Sensitivities of Spliceosomal Mutants in Budding Yeast

Published on: June 30, 2022

2.9K

科学领域:

  • 心脏病学 心脏病学
  • 生物标志物发现发现
  • 诊断医学 诊断医学 诊断医学

背景情况:

  • 急性冠状动脉综合征 (ACS) 的早期诊断至关重要,但具有挑战性.
  • 高灵敏性心脏托罗素 (hs-cTn) 在症状出现后的最初几个小时内有局限性.
  • 心脏肌结合蛋白C (cMyc) 成为ACS的有希望的,早期的,更具体的生物标志物.

研究的目的:

  • 评估心脏肌结合蛋白C (cMyc) 作为急性冠状动脉综合征 (ACS) 的早期诊断生物标志物.
  • 为了比较cMyc的诊断性能与高灵敏度心脏托罗邦素 (hs-cTn).
  • 探索cMyc在各种临床环境中的实用性,包括心肌梗塞亚型和心力衰竭.

主要方法:

  • 在多中心研究中对cMyc与hs-cTn进行比较分析.
  • 将cMyc测试集成到0/1小时诊断算法中.
  • 评估cMyc在心肌梗塞亚型,心脏手术,心力衰竭和医院前设置中的性能.

主要成果:

  • 心脏肌结合蛋白在缺血后30分钟内出现在循环中,达到峰值的速度明显快于hs-cTn.
  • 在非ST段升高心肌梗塞中,cMyc与hs-cTn相结合改善了排除率,从10.9%提高到41.9%.
  • cMyc的心脏特异性N-终端片段 (C0C1f) 最小化了错误阳性,并且通过70分钟的周转时间证明了临床检测的可行性.

结论:

  • 与hs-cTn相比,心脏肌结合蛋白显示出更好的ACS早期诊断能力.
  • cMyc有可能显著改变目前急性冠状动脉综合征的诊断范式.
  • 该生物标志物还显示了心力衰竭和心脏手术背景中的预后价值.